TORONTO, ONTARIO--(Marketwired - Dec. 23, 2013) - Mr. Ian Ihnatowycz, announced today that he acquired 6,600,000 common shares of Trimel Pharmaceuticals Corporation (the "Issuer") at $0.33 per share through his private investment holding company First Generation Capital Inc. The purchase was made on the Canadian public markets.
Following the purchase, the Mr. Ihnatowycz holds a total of 29,452,500 common shares of the Issuer, corresponding to a securityholding percentage, calculated in accordance with National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues of approximately 19.86%.
The securities of the Issuer were acquired for investment purposes. Depending upon the circumstances, Mr. Ihnatowycz may, from time to time, acquire additional securities or related financial instruments of the Issuer or dispose of all or a portion of the securities or related financial instruments of the Issuer previously acquired.
Additional information is provided in the early warning report filed on www.sedar.com.
For further information or a copy of the early warning report please contact:
| First Generation Capital Inc. |
| 40 King Street West |
| Suite 3515 |
| Toronto, ON M5H 3Y2 |
| Attention: Ian Ihnatowycz, President and CEO |
| Telephone: (416) 304-9910 |
Contact Information:
Ian Ihnatowycz
President and CEO
(416) 304-9910